A dose-finding study of nanoparticle albumin-bound paclitaxel plus cisplatin in patients with metastatic nasophyngeal carcinomas.
Li Zhang
Consultant or Advisory Role - AstraZeneca (U); Pfizer (U); Roche (U)
Honoraria - AstraZeneca; Lilly; Roche
Research Funding - Celgene
Wenhua Liang
No relevant relationships to disclose
Yan Huang
No relevant relationships to disclose
Liping Zhao
No relevant relationships to disclose
Hongyun Zhao
No relevant relationships to disclose
Xuan Wu
No relevant relationships to disclose
Tao Qin
No relevant relationships to disclose